Innovative Solutions for Rare Diseases

Rytol Bioscience is dedicated to developing groundbreaking treatments for rare diseases, focusing on brain oncology and central nervous system disorders, including glioma and acute myeloid leukemia.

Transforming lives through innovative therapies.

Dr. Mathew Earlind

"

Leader in Central Nervous System Conditions

Rytol Bioscience develops groundbreaking treatments for rare diseases, focusing on brain oncology and CNS disorders.

Glioma Treatment

First-in-class therapies targeting glioma and enhancing patient outcomes in brain oncology and CNS disorders.

Cancer Therapies

Developing advanced treatments for acute myeloid leukemia, renal cancer, and other critical conditions.

World leader in mRNA

Leading in the development in a first in class mRNA Treatment for select CNS diseases.

Rytol Bioscience develops innovative DNA modifying therapies that address the source of the disease, not just the symptoms. With a primary focus on brain disorders and central nerve diseases

We currently have 5 compounds under clinical development.